secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ainos, Inc. (AIMD)
CIK:        0001014763
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0001654954-24-000521
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ainos enters addendum to product development agreement with affiliate TCNT; defines co-development products and fees
--------------------------------------------------------------------------------

- Addendum specifies co-development products: VOC diagnostics, AI Nose, POCT, VELDONA drug processing, lateral flow diagnostics.
- Ainos to pay TCNT total fee of NT$5M (~USD$161k) over five years starting 2024.
- Non-exclusive patent license for VOC and POCT: US$95k/month (plus 5% tax) for initial six months from Jan 2024.
- TCNT provides facilities, equipment, mass production tech and ISO9001/13485 management; parts, raw materials, utilities excluded.
- Original agreement effective Aug 2021 to Jul 2026; addendum ratified by audit committee on Jan 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1014763/000165495424000521/0001654954-24-000521-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1014763/000165495424000521/aimd_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-000521

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer